Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

Cited by (1,001)

Items 801–900 of 1,001

1. The New NNRTI ACC007 Combined with Lamivudine and Tenofovir Disoproxil Fumarate Show Synergy Anti-HIV Activity In Vitro
   Xusheng Huang, Rong‐Hua Luo, Xiong-Lin Hu, Huan Chen, Si-Ying Xiang, Cheng-Run Tang, Chuntao Zhang, Xiao-Ning Shen, Yong‐Tang Zheng · 2020 · Current HIV Research
2. Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice
   Simone Belmonti, Simona Di Giambenedetto, Francesca Lombardi · 2021 · Diagnostics
3. Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure
   Fengting Wu, Francesco Roberto Simonetti · 2023 · Current HIV/AIDS Reports
4. Transcription of HIV-1 at sites of intact latent provirus integration
   Ana Rafaela Teixeira, Cíntia Bittar, Gabriela S. Silva Santos, Thiago Y. Oliveira, Amy S. Huang, Noemi Linden, Isabella A.T.M. Ferreira, Tetyana Murdza, Frauke Muecksch, Richard Brad Jones et al. · 2024 · The Journal of Experimental Medicine
5. HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral Therapy
   Cecilia Theresa Costiniuk, Mohammad-Ali Jenabian · 2014 · AIDS Patient Care and STDs
6. Recent developments in human immunodeficiency virus-1 latency research
   Chi Ngai Chan, Isabelle Dietrich, Margaret J. Hosie, Brian J. Willett · 2013 · Journal of General Virology
7. Periodic Multidrug Therapy in a Within-Host Virus Model
   Cameron J. Browne, Sergei S. Pilyugin · 2011 · Bulletin of Mathematical Biology
8. Determinants of the efficacy of HIV latency-reversing agents and implications for drug and treatment design
   Ruian Ke, Jessica M. Conway, David M. Margolis, Alan S. Perelson · 2018 · JCI Insight
9. An HIV model with age-structured latently infected cells
   Areej Alshorman, Chathuri Samarasinghe, Wenlian Lu, Libin Rong · 2016 · Journal of Biological Dynamics
10. Current views on HIV-1 latency, persistence, and cure
    Zora Mělková, Prakash Shankaran, Michaela Madlenakova, Josef Bodor · 2016 · Folia Microbiologica
11. The Multifaceted Contributions of Chromatin to HIV-1 Integration, Transcription, and Latency
    Elisa De Crignis, Tokameh Mahmoudi · 2016 · International review of cytology
12. Quercetin synergistically reactivates human immunodeficiency virus type 1 latency by activating nuclear factor‑κB
    Xinyi Yang, Xiaoli Zhu, Haiyan Ji, Junxiao Deng, Panpan Lu, Zhengtao Jiang, Xian Li, Yibo Wang, Chuqiao Wang, Jingya Zhao et al. · 2017 · Molecular Medicine Reports
13. Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents
    Vipul Gupta, Narendra M. Dixit · 2018 · PLoS Computational Biology
14. Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1
    Viviane M. Andrade, Mario Stevenson · 2018 · Journal of Neuroimmune Pharmacology
15. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4 + T Cell Proliferation without Detectable Virus Reactivation in Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Infected Macaques
    Nitasha Kumar, Julia Bergild McBrien, Diane G. Carnathan, Maud Mavigner, Cameron Mattingly, Erick White, Federico Viviano, Steve E. Bosinger, Ann Chahroudi, Guido Silvestri et al. · 2018 · Journal of Virology
16. Have Cells Harboring the HIV Reservoir Been Immunoedited?
    Szu-Han Huang, Chase D. McCann, Talia M. Mota, Chao Wang, Steven M. Lipkin, Richard Brad Jones · 2019 · Frontiers in Immunology
17. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement
    Riddhima Banga, Caterina Rebecchini, Francesco A. Procopio, Alessandra Noto, Olivia Muñoz, Kalliopi Ioannidou, Craig W. Fenwick, Khalid Ohmiti, Matthias L. Cavassini, Jean-Marc Corpataux et al. · 2019 · PLoS Pathogens
18. Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1
    Alessia Bertoldi, Vanessa D’Urbano, Isabella Bon, Annelies Verbon, Casper Rokx, Charles A. Boucher, Jeroen J. A. van Kampen, Rob A. Gruters, Giorgio Gallinella, Leonardo Calza et al. · 2019 · Journal of Virological Methods
19. The Impact of Cellular Proliferation on the HIV-1 Reservoir
    Maria Virgilio, Kathleen L. Collins · 2020 · Viruses
20. Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy
    Roland Schwarzer, Andrea Gramatica, Warner C. Greene · 2020 · Viruses
21. The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary T CM Cell Model of Latency
    Indra Sarabia, Szu-Han Huang, Adam R. Ward, Richard Brad Jones, Alberto Bosque · 2021 · Journal of Virology
22. Lnc(ing)RNAs to the “shock and kill” strategy for HIV-1 cure
    Saikat Boliar, David G. Russell · 2021 · Molecular Therapy — Nucleic Acids
23. HIV-1 can infect northern pig-tailed macaques (Macaca leonina) and form viral reservoirs in vivo
    Wei Pang, Gao‐Hong Zhang, Jin Jiang, Hong‐Yi Zheng, Lin-Tao Zhang, Xiaoliang Zhang, Jia-Hao Song, Ming-Xu Zhang, Jia-Wu Zhu, Ai-Hua Lei et al. · 2017 · 中国科学通报：英文版
24. Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors
    Mercedes Bermejo, Juan Ambrosioni, Guiomar Bautista, Núria Climent, Elena Mateos, Cristina Rovira, Sara Rodríguez-Mora, María Rosa López‐Huertas, Valentín García‐Gutiérrez, Juan Luis Steegmann et al. · 2018 · Biochemical Pharmacology
25. Plasma Viral Load Threshold for Sustaining Intrahost HIV Type 1 Evolution
    Gonzalo Bello, Concha Casado, Virginia Sandonis, Tamara Alvaro-Cifuentes, Caio Alves Santos, Soledad García, Carmen Rodríguez, Jorge del Romero, José Henrique Pilotto, Beatriz Gilda Jegerhorn Grinsztejn et al. · 2007 · AIDS Research and Human Retroviruses
26. Persistence by proliferation?
    David M. Margolis, Frederic D. Bushman · 2014 · Science
27. HIV reservoirs are dominated by genetically younger and clonally enriched proviruses
    Kinloch, Natalie N., Shahid, Aniqa, Dong, Winnie, Kirkby, Don, Jones, Bradley R., Beelen, Charlotte J., MacMillan, Daniel, Lee, Guinevere Q., Mota, Talia M., Sudderuddin, Hanwei et al. · 2023 · mBio
28. Clinical and evolutionary consequences of HIV adaptation to HLA
    Santiago Ávila‐Ríos, Jonathan M. Carlson, Mina John, Simon Alexander Mallal, Zabrina L. Brumme · 2019 · Current Opinion in HIV and AIDS
29. Cellular Activation, Differentiation, and Proliferation Influence the Dynamics of Genetically Intact Proviruses Over Time
    Bethany A. Horsburgh, Bonnie M. Hiener, Katie Fisher, Eunok Lee, Hannah J. Morgan, John‐Sebastian Eden, Susanne von Stockenström, Lina Odevall, Jeffrey M. Milush, Rebecca Hoh et al. · 2021 · The Journal of Infectious Diseases
30. Application of CRISPR/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection
    Alexandra Maslennikova, Dmitriy V. Mazurov · 2022 · Frontiers in Cellular and Infection Microbiology
31. Accuracy of real-time PCR and digital PCR for the monitoring of total HIV DNA under prolonged antiretroviral therapy
    Constance Renault, Karine Bolloré, Amandine Pisoni, Camille Motto-Ros, Philippe Van de Perre, Jacques Reynes, Édouard Tuaillon · 2022 · Scientific Reports
32. Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation
    Manickam Ashokkumar, Wenwen Mei, Jackson J. Peterson, Yuriko Harigaya, David M. Murdoch, David M. Margolis, Caleb Kornfein, Alex Oesterling, Zhicheng Guo, Cynthia D Rudin et al. · 2024 · Genomics Proteomics & Bioinformatics
33. Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians
    Andrés Esteban-Cantos, Rocío Montejano, Adriana Pinto-Martínez, Javier Rodríguez-Centeno, Federico Pulido, José Ramón Arribas · 2024 · The Lancet HIV
34. Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir
    Brandon F. Keele, Afam A. Okoye, Christine M. Fennessey, Benjamin D. Varco-Merth, Taina T. Immonen, Emek Köse, Andrew Conchas, Mykola Pinkevych, Leslie Lipkey, Laura P. Newman et al. · 2024 · PLoS Pathogens
35. CD4+CD25+CD127 regulatory cells play multiple roles in maintaining HIV-1 p24 production in patients on long-term treatment: HIV-1 p24-producing cells and suppression of anti-HIV immunity
    Yan‐Mei Jiao, Cui-E Liu, Li-Jing Luo, Weijun Zhu, Tong Zhang, Li-Guo Zhang, Li-Shan Su, Hong-Jun Li, Hao Wu · 2015 · International Journal of Infectious Diseases
36. Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions
    Nadia T. Sebastian, Kathleen L. Collins · 2014 · Expert Review of Anti-infective Therapy
37. Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population
    Taina T. Immonen, Jessica M. Conway, Ethan Obie Romero-Severson, Alan S. Perelson, Thomas Leitner · 2015 · PLoS Computational Biology
38. Strategies to target non-T-cell HIV reservoirs
    Jonah B. Sacha, Lishomwa C. Ndhlovu · 2016 · Current Opinion in HIV and AIDS
39. Blood biomarkers of expressed and inducible HIV-1
    Anthony Richard Cillo, Francis Hong, Angela Tsai, Alivelu Irrinki, Jasmine Kaur, Derek D. Sloan, Mattie Follen, Romas Geleziunas, Tomáš Cihlář, Sandra S. Win et al. · 2018 · AIDS
40. Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy
    Feiyu F. Hong, Jana L. Jacobs, Evgenia Aga, Anthony Richard Cillo, Elizabeth Fyne, Dianna L. Koontz, Lu Zheng, John W. Mellors · 2018 · Virology
41. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
    Sarah Joseph, Mattia Trunfio, Laura Pesci Kincer, Andrea Calcagno, Richard W. Price · 2019 · AIDS
42. New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
    Katherine M. Bricker, Ann Chahroudi, Maud Mavigner · 2021 · Viruses
43. The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent
    Roger Badía, Judith Grau-Expósito, Eva Riveira‐Muñoz, Ester Ballana, Giuseppe Giannini, José A. Esté · 2015 · Antiviral Research
44. Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Human Cytomegalovirus Immediate‐Early 2 Protein, a Promising Target for Anti‐HCMV Treatment
    Serena Massari, Beatrice Mercorelli, Luca Sancineto, Stefano Sabatini, Violetta Cecchetti, Giorgio Gribaudo, Giorgio Palù, Christophe C. Pannecouque, Arianna Loregian, Oriana Tabarrini · 2013 · ChemMedChem
45. Discrimination of lamivudine resistant minor HIV-1 variants by selective real-time PCR
    Tobias Bergroth, Anders B. Sönnerborg, Zhibing Yun · 2005 · Journal of Virological Methods
46. The SMAC Mimetic AZD5582 is a Potent HIV Latency Reversing Agent
    Gavin C. Sampey, David M. Irlbeck, Edward P. Browne, Matthew Kanke, Alecia B. McAllister, Robert G. Ferris, Jessica H. Brehm, David Favre, Jean‐Pierre Routy, Corbin D. Jones et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
47. Postpartum Discontinuation of Antiretroviral Therapy and Risk of Maternal AIDS-Defining Events, Non-AIDS–Defining Events, and Mortality Among a Cohort of HIV-1–Infected Women in the United States
    Vlada V. Melekhin, Bryan E. Shepherd, Cathy A. Jenkins, Samuel E. Stinnette, Peter F. Rebeiro, Sally S. Bebawy, Daniel A. Rasbach, Todd Hulgan, Timothy R. Sterling · 2010 · AIDS Patient Care and STDs
48. Are Infants Unique in Their Ability to be “Functionally Cured” of HIV-1?
    Nicole H. Tobin, Grace M. Aldrovandi · 2014 · Current HIV/AIDS Reports
49. The dysfunction of T follicular helper cells
    Rafael A. Cubas, Matthieu Perreau · 2014 · Current Opinion in HIV and AIDS
50. CTL Clonotypes with Higher TCR Affinity Have Better Ability to Reduce the HIV Latent Reservoir
    Noemia S. Lima, Hiroshi Takata, Szu-Han Huang, Alexander Haregot, Julie L. Mitchell, Stephen Blackmore, Ayanna Garland, Aaron Sy, Pearline Cartwright, Jean‐Pierre Routy et al. · 2020 · The Journal of Immunology
51. Chemistry and Bioinformatics Considerations in Using Next-Generation Sequencing Technologies to Inferring HIV Proviral DNA Genome-Intactness
    Guinevere Q. Lee · 2021 · Viruses
52. Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus–infected rhesus macaques on antiretroviral therapy
    Benjamin D. Varco-Merth, William Brantley, Alejandra Marenco, Derick D. Duell, Devin N. Fachko, Brian Richardson, Kathleen Busman‐Sahay, Danica Shao, Walter Flores, Kathleen D. Engelman et al. · 2022 · Journal of Clinical Investigation
53. Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure
    Stella J. Berendam, Ashley N. Nelson, Bhrugu Yagnik, Ria Goswami, Tiffany M. Styles, Margaret Neja, Caroline T. Phan, Sedem Dankwa, Alliyah Byrd, Carolina Garrido et al. · 2022 · Frontiers in Immunology
54. Primary cell models of HIV latency
    Hung‐Chih Yang · 2010 · Current Opinion in HIV and AIDS
55. Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.
    Mark Yungjie Jeng, Ibraheem Ali, Mélanie Ott · 2015 · PubMed
56. Quantifying the Turnover of Transcriptional Subclasses of HIV-1-Infected Cells
    Christian Lorenz Althaus, Béda Joos, Alan S. Perelson, Huldrych F. Günthard · 2014 · PLoS Computational Biology
57. Pharmacological Modulation of the Wnt/β-Catenin Pathway Inhibits Proliferation and Promotes Differentiation of Long-Lived Memory CD4 + T Cells in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques
    Maud Mavigner, Michelle Zanoni, Gregory K. Tharp, Jakob G. Habib, Cameron Mattingly, Mathias D. Lichterfeld, Melon T. Nega, Thomas H. Vanderford, S. E. Bosinger, Ann Chahroudi · 2019 · Journal of Virology
58. Assessment of HIV-1 integration in tissues and subsets across infection stages
    Vincent H. Wu, Christopher L. Nobles, Leticia Kuri-Cervantes, Kevin McCormick, J.K. Everett, Son Nguyen, Perla M. Del Río Estrada, Mauricio González-Navarro, Fernanda Torres-Ruiz, Santiago Ávila‐Ríos et al. · 2020 · JCI Insight
59. Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent
    Elias P. Rosen, Claire Deléage, Nicole White, Craig Sykes, Catherine Brands, Lourdes Adamson, Paul A. Luciw, Jacob D. Estes, Angela D. M. Kashuba · 2022 · Journal of the International AIDS Society
60. HIV-1 DNA proviral load in treated and untreated HIV-1 sero-positive patients
    Maria Carla Re, Francesca Vitone, Carlo Biagetti, Pasqua Schiavone, Federica Alessandrini, Isabella Bon, Elisa De Crignis, Davide Gibellini · 2009 · Clinical Microbiology and Infection
61. HIV‐1 DNA burden dynamics in CD4 T cells and monocytes in patients undergoing a transient therapy interruption
    Anna Rosa Garbuglia, Silvia Calcaterra, Gianpiero D’Offizi, Simone Topino, Pasquale Narciso, Flavia B Lillo, Enrico Girardi, Maria Rosaria Capobianchi · 2004 · Journal of Medical Virology
62. Review of "The Twelfth West Coast Retrovirus Meeting" and "The Twenty-third Annual Symposium on Nonhuman Primate Models for AIDS"
    J. Scott Cairns · 2006 · AIDS Research and Therapy
63. Early treatment may not be early enough
    Kai Deng, Robert F. Siliciano · 2014 · Nature
64. Dynamics of the Gene Regulatory Network of HIV-1 and the Role of Viral Non-coding RNAs on Latency Reversion
    Antonio Bensussen, Christian Torres-Sosa, Ramón A. González, José Dı́az · 2018 · Frontiers in Physiology
65. HIV latency reversal agents: A potential path for functional cure?
    Juliana Romano Lopes, Diego Eidy Chiba, Jean Leandro dos Santos · 2021 · European Journal of Medicinal Chemistry
66. Addressing an HIV cure in LMIC
    Sherazaan D. Ismail, Joshua Pankrac, Emmanuel Ndashimye, Jessica L. Prodger, Melissa-Rose Abrahams, Jamie F. S. Mann, Andrew D. Redd, Eric J. Arts · 2021 · Retrovirology
67. Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals
    Brian Moldt, Huldrych F. Günthard, Kimberly Workowski, Susan J. Little, Joseph J. Eron, Edgar Turner Overton, Clara Lehmann, Casper Rokx, Michael J. Kozal, Rajesh Tim Gandhi et al. · 2021 · AIDS
68. Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”
    Chiara Acchioni, Enrico Palermo, Silvia Sandini, Marta Acchioni, John B. Hiscott, Marco Sgarbanti · 2021 · Pathogens
69. Current strategies to induce selective killing of HIV-1-infected cells
    Grant R. Campbell, Stephen A. Spector · 2022 · Journal of Leukocyte Biology
70. HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
    Shuang Li, Christiane Moog, Tong Zhang, Bin Su · 2022 · Chinese Medical Journal
71. A truncated HIV Tat demonstrates potent and specific latency reversal activity
    Ellen R. Van Gulck, Marion Pardons, Erik Nijs, Nick Verheyen, Koen Dockx, Christel Van den Eynde, Emilie Battivelli, Jerel Boyd Vega, Éric Florence, Brigitte Autran et al. · 2023 · Antimicrobial Agents and Chemotherapy
72. CD4+ T cells with latent HIV-1 have reduced proliferative responses to T cell receptor stimulation
    Joshua T. Kufera, Ciara Armstrong, Fengting Wu, Anushka Singhal, Hao Zhang, Jun Lai, Hannah N. Wilkins, Francesco Roberto Simonetti, Janet D'Angelo Siliciano, Robert F. Siliciano · 2024 · The Journal of Experimental Medicine
73. HIV vaccination: Navigating the path to a transformative breakthrough—A review of current evidence
    Godfred Yawson Scott, Dominic Adam Worku · 2024 · Health Science Reports
74. Role of Micro-RNAs in Regulation of Lentiviral Latency and Persistence
    Omar Bagasra, Ariana E. Stir, Lucia A. Pirisi-Creek, Kim E. Creek, Alexander U. Bagasra, Nancy Glenn, Jeremy S. Lee · 2006 · Applied immunohistochemistry & molecular morphology
75. HIV persistence: Chemokines and their signalling pathways
    Vanessa A. Evans, Gabriela Khoury, Suha M. Saleh, Paul U. Cameron, Sharon R. Lewin · 2012 · Cytokine & Growth Factor Reviews
76. Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell Responses
    Sheila Marie Keating, Richard Brad Jones, Christina M. Lalama, Ronald J. Bosch, Deborah K. McMahon, Dylan Hampton, Joshua C. Cyktor, Joseph J. Eron, John W. Mellors, Michael Paul Busch et al. · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
77. Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence
    Matthew R. Weichseldorfer, Alonso Heredia, Marvin S. Reitz, Joseph Bryant, Olga Latinovic · 2020 · Journal of AIDS and HIV Treatment
78. Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size
    Mars Stone, Daniel I. S. Rosenbloom, Peter Bacchetti, Xutao Deng, Melanie Dimapasoc, Sheila Marie Keating, Sonia Bakkour, Douglas D. Richman, John W. Mellors, Steven G. Deeks et al. · 2020 · The Journal of Infectious Diseases
79. CD32+CD4+ memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice
    Philipp Adams, Virginie Fiévez, Rafaëla Schober, Mathieu Amand, Gilles Iserentant, Sofie Rutsaert, Géraldine Dessilly, Guido L. Vanham, Fanny Hedin, Antonio Cosma et al. · 2020 · iScience
80. Total Synthesis and Biological Evaluation of the Potent HIV Latency-Reversing Agent Ansellone A and its Analogues
    Mizushi Yanagihara, Kenichi Murai, Naoki Kishimoto, Towa Abe, Shogo Misumi, Mitsuhiro Arisawa · 2021 · Organic Letters
81. Discovery of Ethyl Ketone-Based Highly Selective HDACs 1, 2, 3 Inhibitors for HIV Latency Reactivation with Minimum Cellular Potency Serum Shift and Reduced hERG Activity
    Wensheng Yu, Jian Liu, Dane J. Clausen, Younong Yu, Joseph L. Duffy, Ming Wang, Shouning Xu, Linhong Deng, Takao Suzuki, Christine C. Chung et al. · 2021 · Journal of Medicinal Chemistry
82. Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infection
    Catherine Burton, Mark Richard Nelson, Phillip Hay, Brian Gazzard, F Gotch, Nesrina Imami · 2005 · Clinical & Experimental Immunology
83. Hsp90: a chaperone for HIV-1
    Jun Siong Low, Ariberto Fassati · 2014 · Parasitology
84. A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice
    Harry D. J. Knights · 2017 · AIDS Research and Treatment
85. Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy
    Yolanda Barrón, Stephen R. Cole, Ruth M. Greenblatt, Mardge H. Cohen, Kathryn Anastos, Jack A. DeHovitz, Robert Delapenha, Stephen J. Gange · 2004 · AIDS
86. An anti-CD45RO immunotoxin kills HIV-latently infected cells from individuals on HAART with little effect on CD8 memory
    Jesús Saavedra‐Lozano, Yanying Cao, Julie A. Callison, Ravi Sarode, Donald L. Sodora, John B. Edgar, Jeanine Hatfield, Louis J. Picker, D. M. Peterson, Octavio Ramilo et al. · 2004 · Proceedings of the National Academy of Sciences
87. Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion
    Alan S. Perelson, Tin Phan, Jessica M. Conway, Nicole Pagane, Jasmine A. F. Kreig, Narmada Sambaturu, Sarafa Adewale Iyaniwura, Jonathan Z Li, Ruy M. Ribeiro, Ruian Ke · 2024 · PLoS Pathogens
88. HIV‐1 evolution in relation to molecular epidemiology and antiretroviral resistance
    Helena Skar, Charlotte Hedskog, Jan Albert · 2011 · Annals of the New York Academy of Sciences
89. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy
    F. Harrison Omondi, Hanwei Sudderuddin, Aniqa Shahid, Natalie N. Kinloch, Bradley R. Jones, Rachel L. Miller, Olivia Tsai, Daniel MacMillan, Alicja Piechocka‐Trocha, Mark A. Brockman et al. · 2021 · mBio
90. Latency-associated DNA methylation patterns among HIV-1 infected individuals with distinct disease progression courses or antiretroviral virologic response
    Nathalia Mantovani, Alexandre Defelicibus, Israel Tojal da Silva, Maira Ferreira Cicero, Luiz Claudio Santana, Rafael Arnold, Daniela Funayama de Castro, Rodrigo Lopes Sanz Duro, Milton Yutaka Nishiyama, Inácio L.M. Junqueira-de-Azevedo et al. · 2021 · Scientific Reports
91. Mathematical Models of HIV-1 Dynamics, Transcription, and Latency
    Iván D’Orso, Christian V. Forst · 2023 · Viruses
92. Reduced evolutionary rates in HIV-1 reveal extensive latency periods among replicating lineages
    Taina T. Immonen, Thomas Leitner · 2014 · Retrovirology
93. Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy
    Daniel Sánchez‐Taltavull, A. Vieiro, Tomás Alarcón · 2016 · Journal of Mathematical Biology
94. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4+ T cells on ART
    Maria Carmen Puertas, Marc Noguera-Julián, Marta Massanella, Christian Pou, Maria José Buzón, Bonaventura Clotet, Mario Stevenson, Roger Paredes, Julià Blanco, Javier Martínez‐Picado · 2016 · Retrovirology
95. Insufficient Evidence for Rare Activation of Latent HIV in the Absence of Reservoir-Reducing Interventions
    Alison L. Hill, Daniel I. S. Rosenbloom, Janet D'Angelo Siliciano, Robert F. Siliciano · 2016 · PLoS Pathogens
96. Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells
    Nitasha Kumar, Renée Marije van der Sluis, Talia M. Mota, Rachel D. Pascoe, Vanessa A. Evans, Sharon R. Lewin, Paul U. Cameron · 2018 · The Journal of Immunology
97. Does B Cell Follicle Exclusion of CD8+ T Cells Make Lymph Nodes Sanctuaries of HIV Replication?
    Sarah E. Beck, Rebecca T. Veenhuis, Joel N. Blankson · 2019 · Frontiers in Immunology
98. PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5′ Long Terminal Repeat
    Zhangping He, Shuliang Jing, Tao Yang, Jingliang Chen, Feng Huang, Wanying Zhang, Zhilin Peng, Bingfeng Liu, Xiancai Ma, Liyang Wu et al. · 2020 · Journal of Virology
99. Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy
    Yanina Ghiglione, María L. Polo, Alejandra Urioste, Ajantha Rhodes, Alejandro Czernikier, César Trifone, María Florencia Quiroga, Alicia E Sisto, Patricia Patterson, Horacio Salomón et al. · 2020 · Open Forum Infectious Diseases
100. Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome
     Joseph Francis Hokello, Adhikarimayum Lakhikumar Sharma, Mudit Tyagi · 2020 · Viruses